Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy
HTML
Details
Locations
Year:
2007
Type:
article
Source:
Oncogene
DOI:
10.1038/sj.onc.1210514
Authors:
S Glaros,
G M Cirrincione,
C Muchardt,
C G Kleer,
C W Michael,
D Reisman
show all 6
Institutions:
University of Michigan,
Michigan Medicine,
Centre National de la Recherche Scientifique,
Institut Pasteur
Language:
English
Topic:
Chromatin Remodeling and Cancer
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
closed
Funders:
University of Michigan,
National Institutes of Health,
National Cancer Institute,
National Institute of Diabetes and Digestive and Kidney Diseases
Awards:
G2055771504,
Alterations of the Human SWI/SNF Complex in Lung Cancer,
G3485852046,
G357379557,
University of Michigan Rogel Cancer Center Support Grant 2023-2028
OpenAlex ID:
W2038756571
FWCI:
2.784
Cites:
20
Cited by:
148
Related to:
10